We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Resistive Pulse Sensing Allows Measurement of Individual Biological Particles

By LabMedica International staff writers
Posted on 02 Aug 2012
Print article
Image: The qNano bench-top nanoparticle analysis instrument (Photo courtesy of Izon Science).
Image: The qNano bench-top nanoparticle analysis instrument (Photo courtesy of Izon Science).
An international team of biotech researchers has used an ultrasensitive nanoparticle analysis system to detect and measure the agglutination of biological molecules at the level of the individual particle.

The team comprised of investigators from Loughborough University (Leicestershire, United Kingdom) and University College Dublin (Ireland) worked with an Izon Science (Christchurch, New Zealand) qNano instrument.

The qNano uses resistive pulse sensing to monitor individual and aggregated rod-shaped nanoparticles as they move through tunable pores in elastomeric membranes. A discrete blockade event signal is recorded by the system each time a particle traverses the nanopore. The magnitude of a measured blockade signal is a key indicator of the volume (or equivalent diameter) of the particle that has passed through the pore.

The qNano instrument is described by its manufacturer as a rapid, accurate, and convenient solution for evaluation of particle size and size distribution of nanoparticle samples in a fluid. Particle-by-particle detection ensures an accurate size distribution output without the averaging effects inherent in other size analysis technologies.

In a paper published in the May 9, 2012, online edition of the journal Small the investigators described the use of the qNano instrument to investigate the agglutination of biological molecules. By controlling the surface chemistry and location of the capture ligand, molecular rods were made to form either long “end-on-end” or wide “side-on” aggregates upon the addition of an analyte. They demonstrated the binding of a biotinylated target to an avidin capture probe, followed by the detection of platelet-derived growth factor (PDGF-BB) using an aptamer capture probe, with limits of detection down to femtomolar levels. This observation will facilitate multiplexed detection in agglutination assays, as particles with a particular aspect ratio can be distinguished by only two measurements.

First author Dr. Mark Platt, lecturer in analytical chemistry at Loughborough University, said, "The strength of using the qNano is its simplicity and the ability to interrogate individual particles through a nanopore. This allowed us to establish a very sensitive measurement of concentration because we could detect the interactions occurring down to individual particle level. By comparing particles of similar dimensions we demonstrated that the resistive pulse signal is fundamentally different for rod and sphere-shaped particles, and for rod shaped particles of different lengths. We could exploit these differences in a new agglutination assay to achieve these low detection levels."

"This is a real milestone for Izon's technology as being able to measure biomolecules down to these extremely low levels opens up new bio-analysis options for researchers. 10 femtomolar was achieved, which is the equivalent dilution to one gram in 3.3 billion liters, or one gram in 1,300 Olympic sized swimming pools," said Hans van der Voorn, executive chairman of Izon Science. "We are now developing standardized diagnostics kits for researchers which will allow them to optimize protocols for their particular targets of interest."

Related Links:
Loughborough University
University College Dublin
Izon Science


New
Gold Member
Veterinary Hematology Analyzer
Exigo H400
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
New
MTHFR Mutation Test
REALQUALITY THROMBO MTHFR
New
Automated Biochemistry Analyzer
AutoChem B861

Print article

Channels

Molecular Diagnostics

view channel
Image: A coronal MRI section shows a high-intensity focused ultrasound lesion in the left thalamus of the brain (Photo courtesy of UT Southwestern Medical Center)

Newly Identified Stroke Biomarkers Pave Way for Blood Tests to Quickly Diagnose Brain Injuries

Each year, nearly 800,000 individuals in the U.S. experience a stroke, which occurs when blood flow to specific areas of the brain is insufficient, causing brain cells to die due to a lack of oxygen.... Read more

Immunology

view channel
Image: The discovery of biomarkers could improve endometrial cancer treatment (Photo courtesy of Mount Sinai)

Simple Blood Test Could Help Choose Better Treatments for Patients with Recurrent Endometrial Cancer

Endometrial cancer, which develops in the lining of the uterus, is the most prevalent gynecologic cancer in the United States, affecting over 66,000 women annually. Projections indicate that in 2025, around... Read more

Pathology

view channel
Image: As tumor cells flow through these microfluidic chambers, they are subjected to increasing shear stress and sorted based on their adhesion strength (Photo courtesy of UC San Diego)

Microfluidic Device Assesses Stickiness of Tumor Cells to Predict Cancer Spread

Ductal carcinoma in situ (DCIS), a type of early-stage breast cancer, is often referred to as stage zero breast cancer. In many cases, it remains harmless and does not spread beyond the milk ducts where... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.